Clinical Research Services
|
|
- Jennifer Watkins
- 6 years ago
- Views:
Transcription
1 Jeevan Scientific Technology Limited a symbol of quality and diverse solutions Clinical Research Services
2 JEEVAN SCIENTIFIC TECHNOLOGY LIMITED Jeevan Scientific is an Independent Contract Research Organization, established in the year 1999, located in Hyderabad, India. In 2015, Jeevan incorporated its US arm. Jeevan has been built with state of the art facilities and expert resources to provide broad range of clinical research services for healthcare/pharmaceutical industries across the globe. Jeevan s service portfolio hosts a spectrum of services that enables us to provide an integrated solution for the management of clinical development right from its inception to completion and post-marketing. Jeevan is a perfect blend of technology, innovation and expertise, which enables us to provide reliable, cost-effective and technology driven services and solutions to clients. MISSION, VISION & VALUES To realize our Vision of being a clinical research organization (CRO) with global distinction, we ensure that our services adhere to the highest standards, which are at par with global quality standards, and set new benchmarks. Jeevan s quality policy is to achieve sustained and profitable growth by providing services, which consistently satisfy or exceed the needs and expectations of clients. Jeevan has continued to grow and evolve by attracting superior talent, developing valuable resources and investing in state-of-the-art facilities to deliver clients the best. Our commitment to quality, and customer-focused approach bundled with outstanding expertise distinguishes us from others.
3 SERVICE PORTFOLIO Clinical Operations CDM Ÿ BA/BE (Healthy/Patient) Ÿ Data management Ÿ Phase II to IV Ÿ Biostatistics and statistical Ÿ Trial Management programming services Ÿ Trial Supply Management Bioanalytical Pharmacovigilance Ÿ Subject sample analysis Ÿ Case processing Ÿ MD & MV Ÿ Aggregate reports Ÿ Pre-clinical samples Ÿ Signal detection and Risk management plans Regulatory Affairs Project Management Ÿ Dossier Management Ÿ Clinical site management Ÿ Strategy and Intelligence Ÿ Site identification and Vendor Ÿ Labeling and Publishing Ÿ Business & Outsourcing management Ÿ Monitoring reports review and submission Medical Writing Quality Assurance Ÿ Commercial Writing Ÿ Investigator, CRO site and Ÿ Scientific Writing qualification audits Ÿ Preparing investigator sites for inspections Ÿ Site monitoring services Ÿ For cause audits Ÿ Medical Writing and Technical Writing
4 CLINICAL OPERATIONS Services Ø Healthy subject and Patient based BE studies Ø Mixed gender studies Ø Post menopausal studies Ø PK/PD end point studies Ø Food and Drug interaction studies Ø Single and double blind studies Ø Studies on controlled drug substances Ø Single and Multiple dose studies (fast and fed) Ø Dose escalation studies Ø Execution of studies on various range of formulations like Orals (solid oral and liquid oral), injectable and inhalations Infrastructure Ø Dedicated Clinical facility with floor space of 20,000sq.ft Ø 4 independent access controlled clinic units with total of 132 beds Ø 2 ICU units each consist of 4 beds with all emergency equipment's Ø Biometric based software for volunteer registration Ø In-house Clinical diagnostic laboratory Ø Access controlled pharmacy with special provision to store controlled substances Ø Qualified medical staff (DM, MDs, general physicians and Paramedical team) Ø Temperature monitoring devices across the facility Patient based studies Ø Rich pool of clinical investigators across the country Ø Experience in wide range of therapeutic areas Ø Trial and Site management/monitoring by qualified and experienced CRAs Ø Dedicated Project Management for tracking of project and timely monitoring of data to help sponsor remain consistently aware of project status
5 BIOANALYTICAL RESEARCH Services Ø Method Development, method validation (MD and MV) and analysis of samples for clinical trials Pharmacokinetic studies BA/BE studies Drug interaction studies Early phase studies Ø Estimation of drugs and metabolites in biological matrix (using extraction techniques: SPE, LLE) of sample from pre-clinical and clinical studies Ø MD/MV of highly sensitive analysis Infrastructure Ø Dedicated Bio-analytical facility with floor space of 5000 Sq.Ft Ø Having provision to accommodate up to 12 LC-MS/MS Ø High end equipments (LC-MS/MS) with validated software Ø Provisions for handling of both normal and light sensitive molecules Ø New method development and validation is continuous process Ø Access controlled sample storage area with 24X7 sample receipt and monitoring Ø Method development and validation by Qualified and experienced team Ø Online temperature monitoring through Eurotherm
6 DATA MANAGEMENT, PHARMACOKINETIC & STATISTICAL ANALYSIS) Services Ø Customized Data Management services Assistance in study design CRF/e-CRF design Tables, Listings and graphs Preparation of Randomization schedules Development of Statistical analysis plan (SAP) Ø PK analysis and data simulation by using WinNonlin Ø Statical analysis by using validated tools like SAS Ø Development of report in e-ctd format Ø EDC (Electronic Data Capture) QUALITY ASSURANCE AT JEEVAN Ø Independent Quality Assurance Department & robust Quality Management System. Ø All projects performed at Jeevan are audited by our quality assurance department for compliance to USFDA, EMEA and other applicable regulations by following ICH-GCP guidelines and compliance. Ø Experience in handling several regulatory audits like UKMHRA, USFDA, Health Canada, WHO, ANVISA and MOH-Turkey PROJECT MANAGEMENT Ø All projects are handled by technically qualified and experienced project management team Ø Our Project managers have robust knowledge on global project management skills and experience in handling global projects Ø Representing the client in inside the organization by providing best support. Ø Our experienced PM will predict the possible risks of the project and ready with the mitigation strategies beforehand.
7 KEY DIFFRENTIATION Independent CRO Move smarter to patient studies Site relationships and multi-center study management expertise, coupled with therapeutic knowledge, help you successfully deliver early patient studies Public limited company Enhance your capabilities without adding fixed costs Experienced staff, global state-of-the-art facilities and clinical site relationships facilitate studies across a range of therapeutic areas, geography, size and complexity Experienced global project managers Pro-actively prepare solutions and take ownership of project and its deliverables Enhanced site performance Jeevan actively manages each site, ensuring that all protocols are followed and all goals are reached. Variablize costs and share risk Innovative partnering and alliance models reduce infrastructure costs and enhance strategic capacity planning. Effective study management Our Experienced project managers ensure consistent global procedures, rigorous oversight and easy access to integrated data.
8 Advantages with Jeevan Fully integrated scientific expertise team Leadership team at Jeevan has 125 years of Cumulative experience Hands on experience handling various projects in diverse therapeutic areas Team has experience in Execution of more than 1500 clinical research projects Offering varied range of clinical research services across Phase I to IV Global Operations Plot No. 1&2, Sai Krupa Enclave Near Lanco Hills, Golconda (PO) Hyderabad , INDIA US Of ce N Central Expy, Suite 8031 Dallas TX bd@jeevanscientific.com
What does GLP mean in regulated Bioanalysis or Biomarker Bioanalysis
What does GLP mean in regulated Bioanalysis or Biomarker Bioanalysis Philip Timmerman, on behalf of the EBF EBF 9 th Open Symposium 16-18 November 2016 Barcelona Theme of today Plasma samples will be analyzed
More informationClinical Trials Innovation Programme October 22-23, 2015 Frankfurt, Germany Accell Clinical Research, LLC
New Russian Drug Law: Changes Concerning Clinical Studies and Marketing Authorization and Their Implications Dr. Natalia Nayanova Director, Clinical Operations Accell Clinical Research Clinical Trials
More informationCLINICAL TRIAL AGREEMENT [Identification of the trial, Person in charge of research] Sponsor of the Trial: Institution:
CLINICAL TRIAL AGREEMENT [Identification of the trial, Person in charge of research] Sponsor of the Trial: Institution: 2 (20) APPENDIX 1 Parties................................ 4 2 Scope of the agreement................................4
More informationSubtitle F Medical Device Innovations
130 STAT. 1121 (B) unless specifically stated, have any effect on authorities provided under other sections of this Act, including any regulations issued under such sections.. (b) CONFORMING AMENDMENTS.
More informationREPORT 2013/122 INTERNAL AUDIT DIVISION. Audit of United Nations High Commissioner for Refugees operations in Nepal
INTERNAL AUDIT DIVISION REPORT 2013/122 Audit of United Nations High Commissioner for Refugees operations in Nepal Overall results relating to the effective management of UNHCR operations in Nepal were
More informationHRP-103-SOP-Appendix A-3: Additional Requirements for Clinical Trials (ICH-GCP)
HRP-103-SOP-Appendix A-3: Additional Requirements for Clinical Trials (ICH-GCP) 1. Investigator's Qualifications and Agreements a. The clinical trial should be conducted in accordance with the ethical
More informationCanadian Pesticide Compliance and Enforcement Overview
Canadian Pesticide Compliance and Enforcement Overview Presentation to AAPCO March 6, 2016 Diana Dowthwaite Director General, Compliance, Laboratory Services and Regional Operations Directorate Pest Management
More informationTHE BUSINESS IMMIGRATION GROUP
THE BUSINESS IMMIGRATION GROUP YOUR GLOBAL EMPLOYEES: Where you want them. When you need them. In today s global business environment, it s already a challenge to find employees and managers with the best
More informationRussia and Ukraine: Conducting Clinical Trials in an Emerging Market
Russia and Ukraine: Conducting Clinical Trials in an Emerging Market 1 Introductions Ø Andrei Kravchenko, MD, PhD Ø Corporate Director Medical Affairs, General Manager Ukraine Ø Clinipace Worldwide Polling
More informationMONITORING PLAN. Ambition-cm AMBIsome Therapy Induction OptimizatioN London School of Hygiene and Tropical Medicine
MONITORING PLAN Title of study Acronym Sponsor High Dose AMBISOME on a Fluconazole Backbone for Cryptococcal Meningitis Induction Therapy in sub-saharan Africa: A Phase III Randomized Controlled Noninferiority
More informationState of Florida Department of Business and Professional Regulation Division of Drugs, Devices, and Cosmetics
State of Florida Department of Business and Professional Regulation Division of Drugs, Devices, and Cosmetics Application for Limited Prescription Drug Veterinary Wholesale Distributor Form.: DBPR-DDC-219
More informationChapter One. Section I. General provisions
LAW ON MEDICAL DEVICES In force from 12.06.2007 Published SG * No.46 of 12 June 2007 Chapter One GENERAL PRINCIPLES Section I. General provisions Article 1. (1) This Law shall regulate: 1. the conditions
More informationState of Florida Department of Business and Professional Regulation Division of Drugs, Devices, and Cosmetics
State of Florida Department of Business and Professional Regulation Division of Drugs, Devices, and Cosmetics Application for Permit as a Prescription Drug Manufacturer Form.: DBPR-DDC-201 APPLICATION
More informationState of Florida Department of Business and Professional Regulation Division of Drugs, Devices, and Cosmetics
State of Florida Department of Business and Professional Regulation Division of Drugs, Devices, and Cosmetics Application for Third Party Logistic Provider Permit Form.: DBPR-DDC-220 APPLICATION CHECKLIST
More information21 CFR Part 50 - Protection of Human Subjects
21 CFR Part 50 - Protection of Human Subjects Subpart A General Provisions 50.1 Scope. 50.3 Definitions. Subpart B Informed Consent of Human Subjects 50.20 General requirements for informed consent. 50.21
More informationState of Florida Department of Business and Professional Regulation Division of Drugs, Devices, and Cosmetics
State of Florida Department of Business and Professional Regulation Division of Drugs, Devices, and Cosmetics Application for a Restricted Prescription Drug Distributor Reverse Distributor Form.: DBPR-DDC-209
More informationThe Angola National ID Card
The Angola National ID Card Advanced document security for a widely dispersed population 25 by Uwe Ludwig The Republic of Angola in south-central Africa is bordered by Namibia to the South, the Democratic
More informationHEALTH INFORMATION ACT
Province of Alberta HEALTH INFORMATION ACT Revised Statutes of Alberta 2000 Current as of June 13, 2016 Office Consolidation Published by Alberta Queen s Printer Alberta Queen s Printer Suite 700, Park
More informationConstitution - Article 1
NAME, MISSION AND PRINCIPLES Constitution - Article 1 1.1 Name This network shall be known as the European Huntington s Disease Network and referred to in this Constitution as EHDN. 1.2. Mission EHDN aims
More informationNational Research Council Canada (NRC)
National Research Council Canada (NRC) NRC Research Ethics Board (NRC-REB) Standard Operating Procedures (SOPs) 1. GENERAL The NRC Research Ethics Board (NRC-REB) helps NRC and its researchers maintain
More informationGENERAL ASSEMBLY OF NORTH CAROLINA SESSION 2015 H 3 HOUSE BILL 372 Committee Substitute Favorable 6/11/15 Committee Substitute #2 Favorable 6/18/15
GENERAL ASSEMBLY OF NORTH CAROLINA SESSION 01 H HOUSE BILL Committee Substitute Favorable //1 Committee Substitute # Favorable /1/1 Short Title: 01 Medicaid Modernization. (Public) Sponsors: Referred to:
More informationEuropean Medicines Agency Inspections
European Medicines Agency Inspections London, 27 July 2007 Doc. Ref.: EMEA/INS/GCP/239486/2007 MANDATE, OBJECTIVES AND RULES OF PROCEDURE FOR THE GCP INSPECTORS WORKING GROUP (GCP IWG) I. GENERAL CONSIDERATIONS
More informationClinical Trial Research Agreement
Clinical Trial Research Agreement Investigator-Initiated, Company Supported Studies The body of the Agreement is not to be amended. Revisions are to be detailed in Schedule 3 with appropriate cross-referencing
More informationStatement on Security & Auditability
Statement on Security & Auditability Introduction This document is designed to assist Hart customers by providing key facts and support in preparation for the upcoming November 2016 election cycle. It
More informationFrequently Asked Questions for Participating Members and Organizations
Frequently Asked Questions for Participating Members and Organizations Version 3.0.0 SWAC is a trademark of Secure Worker Access Consortium, LLC. 2010 Secure Worker Access Consortium LLC Page 2 of 9 Ref:
More informationFollow-up to the recommendations of the Board of Auditors on the financial statements for previous years
Executive Committee of the High Commissioner s Programme Standing Committee 62 nd meeting Distr.: Restricted 10 February 2015 English Original: English and French Follow-up to the recommendations of the
More informationREPORT 2016/024 INTERNAL AUDIT DIVISION
INTERNAL AUDIT DIVISION REPORT 2016/024 Audit of information and communications technology support provided to the Office of the United Nations High Commissioner for Refugees field operations Overall results
More informationKey Considerations for Implementing Bodies and Oversight Actors
Implementing and Overseeing Electronic Voting and Counting Technologies Key Considerations for Implementing Bodies and Oversight Actors Lead Authors Ben Goldsmith Holly Ruthrauff This publication is made
More informationBelton I.S.D. Records Management Policy and Procedural Manual. Compiled by: Record Management Committee
Belton I.S.D. Records Management Policy and Procedural Manual Compiled by: Record Management Committee Table of Contents I. Definitions and Purpose Pages 3-5 II. Roles and Responsibilities Pages 6-8 III.
More informationState of Florida Department of Business and Professional Regulation Division of Drugs, Devices, and Cosmetics
State of Florida Department of Business and Professional Regulation Division of Drugs, Devices, and Cosmetics Application for Restricted Prescription Drug Distributor Government Programs Permit Form.:
More informationMidwest Stem Cell Therapy Center; Utilization of Unused Medications Act; SB 199
Midwest Stem Cell Therapy Center; Utilization of Unused Medications Act; SB 199 SB 199 enacts new law requiring the University of Kansas Medical Center (KUMC) to establish the Midwest Stem Cell Therapy
More informationState of Florida Department of Business and Professional Regulation Division of Drugs, Devices, and Cosmetics
State of Florida Department of Business and Professional Regulation Division of Drugs, Devices, and Cosmetics Application for Restricted Prescription Drug Distributor Reverse Distributor permit Form.:
More informationDepartment of Health and Mental Hygiene Laboratories Administration
Audit Report Department of Health and Mental Hygiene Laboratories Administration March 2016 OFFICE OF LEGISLATIVE AUDITS DEPARTMENT OF LEGISLATIVE SERVICES MARYLAND GENERAL ASSEMBLY For further information
More informationREPORT 2014/154 INTERNAL AUDIT DIVISION
INTERNAL AUDIT DIVISION REPORT 2014/154 Audit of contract management and vendor performance monitoring in the Office of the United Nations High Commissioner for Refugees Overall results relating to contract
More informationHaving regard to the Treaty establishing the European Economic Community, and in particular Article 100 thereof;
DIRECTIVE 75/319/EEC Council Directive 75/319/EEC of 20 May 1975 on the approximation of provisions laid down by law, regulation or administrative action relating to medicinal products (OJ No L 147 of
More informationONTARIO REGULATION 544/94 GENERAL PROPOSED AMENDMENTS TO QUALITY ASSURANCE REGULATION AND RATIONALE CHART (February 2017)
ONTARIO REGULATION 544/94 GENERAL PROPOSED AMENDMENTS TO QUALITY ASSURANCE REGULATION AND RATIONALE CHART (February 2017) CURRENT REGULATION PROPOSED AMENDMENTS RATIONALE / COMMENTS GENERAL 28. In this
More information2016 Safety Award Entry
2016 Safety Award Entry Category: Best Safety Innovation Entrant: Contact: Julie Bollenbach Email: julie@ariaenergy.com Phone: 248-380-3920 SWANA Member Number: 978027 Title of Entry: Effective Employee
More informationPatients and TB: Improving treatment outcomes through a patient centred approach and access to new treatments
Patients and TB: Improving treatment outcomes through a patient centred approach and access to new treatments 5 th TB Symposium Eastern Europe and Central Asia Ministry of Labour, Health and Social Affairs
More informationREPORT 2016/100 INTERNAL AUDIT DIVISION. Audit of the operations in Niger for the Office of the United Nations High Commissioner for Refugees
INTERNAL AUDIT DIVISION REPORT 2016/100 Audit of the operations in Niger for the Office of the United Nations High Commissioner for Refugees Overall results relating to the effective management of the
More informationSubpart A General Provisions
Pt. 11 necessitated such an action within 24 hours or sooner if requested by the Deputy Commissioner. In the absence or unavailability of the Deputy Commissioner, the presiding officer shall notify the
More informationA Review Of Public Health Pesticides Registration System In Selected SEA Countries
A Review Of Public Health Pesticides Registration System In Selected SEA Countries By Halimi Mahmud Pesticides Board, Malaysia International Public Health Pesticides Workshop 29 September - 1 October 2009,
More informationSands Capital Management, LLC. Proxy Voting Policy and Procedures
Sands Capital Management, LLC Proxy Voting Policy and Procedures Most Recent Amendment: January 2011 Implementation Date: November 2006 Issue Rule 206(4)-6 under the Advisers Act requires every registered
More informationAmendments to Healthcare Research
This is a controlled document. The master document is posted on the JRCO website and any print-off of this document will be classed as uncontrolled. Researchers and their teams may print off this document
More informationMandate, objectives and rules of procedure
12 September 2013 Compliance and Inspections Good Clinical Practice Inspectors Working Group (GCP IWG) 1. General considerations In 1997, the Ad Hoc Meeting of GCP Inspection Services was established by
More informationPEPSICO, INC. CORPORATE GOVERNANCE GUIDELINES. As of February 5, 2018
PEPSICO, INC. CORPORATE GOVERNANCE GUIDELINES As of February 5, 2018 The Board of Directors (the Board ) of PepsiCo, Inc. (the Corporation ), acting on the recommendation of its Nominating and Corporate
More informationBetter and faster development: the regulators perspective on B/R assessment in orphan medicinal products
Better and faster development: the regulators perspective on B/R assessment in orphan medicinal products Violeta Stoyanova, MD, PhD, MPH COMP member NL Rare Disease Patient in 2030 March 30 th, 2017, Amsterdam
More informationWHO Open Forum: IMPACT frequently asked questions
WHO Open Forum: IMPACT frequently asked questions 1. What is the background to WHO's and Member States' activities on counterfeit medicines? World Health Assembly (WHA) resolution 41.16 (1988) requested
More informationNATIONAL POLICY GUIDANCE FOR PROXY ADVISORY FIRMS
NATIONAL POLICY 25-201 GUIDANCE FOR PROXY ADVISORY FIRMS PART 1 PURPOSE AND APPLICATION 1.1 Purpose of this Policy The Canadian Securities Administrators (CSA or we) recognize that proxy voting is an important
More informationAssembly Bill No. 602 CHAPTER 139
Assembly Bill No. 602 CHAPTER 139 An act to amend Sections 4057, 4081, and 4301 of, and to add Sections 4025.2, 4084.1, and 4160.5 to, the Business and Professions Code, relating to pharmacy, and declaring
More informationSECURITY, ACCURACY, AND RELIABILITY OF TARRANT COUNTY S VOTING SYSTEM
SECURITY, ACCURACY, AND RELIABILITY OF TARRANT COUNTY S VOTING SYSTEM Updated February 14, 2018 INTRODUCTION Tarrant County has been using the Hart InterCivic eslate electronic voting system for early
More informationTERMS OF REFERENCE FOR AUSTRIAN TECHNICAL ASSISTANCE TO SADC ENERGY THEMATIC DIVISION
TERMS OF REFERENCE FOR AUSTRIAN TECHNICAL ASSISTANCE TO SADC ENERGY THEMATIC DIVISION 1. Background 1.1 Southern African Development Community (SADC) Member States are undergoing a sustained period of
More informationFrequently Asked Questions for Participating Members and Organizations
Frequently Asked Questions for Participating Members and Organizations Version 3.0.6 SWAC is a trademark of Secure Worker Access Consortium, LLC. Table of Contents ABOUT SWAC... What is SWAC?... 3 What
More informationVUSUMUZI MKHIZE 16 January 2017
Tracing Citizenship and Genealogy through Digitization: South Africa s post apartheid conduit for archival practice and Natural justice VUSUMUZI MKHIZE 16 January 2017 TABLE OF CONTENT Vision, Mission,
More informationFIRST COAST HEALTH ALLIANCE, LLC CHARTER AUDIT AND FINANCE COMMITTEE
AUDIT AND FINANCE COMMITTEE 1. Establishment and Purpose. The Audit and Finance Committee is established by the Board for the purpose of overseeing the integrity of the Company s financial statements and
More informationUniversity of California, San Francisco Helen Diller Family Comprehensive Cancer Center Policy and Procedure. PRMS Amendment Review Policy
University of California, San Francisco Helen Diller Family Comprehensive Cancer Center Policy and Procedure PRMS Amendment Review Policy PRMS Procedure for Review of Protocol Amendments by the Protocol
More informationCOLLEGE OF OPTOMETRISTS OF BRITISH COLUMBIA. Bylaws
COLLEGE OF OPTOMETRISTS OF BRITISH COLUMBIA Bylaws DEFINITIONS (SECTION 1)... 1 PART 1 COLLEGE BOARD, COMMITTEES AND PANELS (SECTIONS 2 TO 26)... 3 Composition of the board... 3 Eligibility for election
More informationHuntington Bancshares Incorporated Subject: Risk Oversight Committee Charter Number: CH-006
1 of 5 Purpose of Committee The Risk Oversight Committee (Committee) is established by the (Board) to assist the Board in: Oversight through the Risk Management function of senior management implementation
More informationProject management / construction management (PM/CM) roles of Client representative for the duration of the Project include
Project management / construction management (PM/CM) roles of Client representative for the duration of the Project include Ø Representation of the Client for the duration of the Project Ø Management and
More information(Acts whose publication is obligatory) of 23 February 2005
16.3.2005 EN Official Journal of the European Union L 70/1 I (Acts whose publication is obligatory) REGULATION (EC) NO 396/2005 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 23 February 2005 on maximum
More informationDIVISION E--INFORMATION TECHNOLOGY MANAGEMENT REFORM
DIVISION E--INFORMATION TECHNOLOGY MANAGEMENT REFORM SEC. 5001. SHORT TITLE. This division may be cited as the `Information Technology Management Reform Act of 1995'. SEC. 5002. DEFINITIONS. In this division:
More informationAPPLICATION TO BECOME A LICENSED PRODUCER UNDER THE ACCESS TO CANNABIS FOR MEDICAL PURPOSES REGULATIONS (ACMPR) (Disponible en français)
APPLICATION TO BECOME A LICENSED PRODUCER UNDER THE ACCESS TO CANNABIS FOR MEDICAL PURPOSES REGULATIONS (ACMPR) (Disponible en français) For guidance on completing this application please refer to the
More informationNEST Coordinating Center (NESTcc) Charter. Article I: Name, Preamble, Mission, and Vision
NEST Coordinating Center (NESTcc) Charter Article I: Name, Preamble, Mission, and Vision Section 1: Name The National Evaluation System for health Technology Coordinating Center (hereinafter called NESTcc
More information(9) Adequacy of electric electronic detection and alarm systems, if any, including use of supervised transmittal lines and standby power sources;
ACTION: Final DATE: 08/01/2017 9:20 AM 4729-9-05 Security requirements. (A) All licensees and registrants shall provide effective and approved controls and procedures to deter and detect theft and diversion
More informationIC Chapter 15. Ballot Card and Electronic Voting Systems; Additional Standards and Procedures for Approving System Changes
IC 3-11-15 Chapter 15. Ballot Card and Electronic Voting Systems; Additional Standards and Procedures for Approving System Changes IC 3-11-15-1 Applicability of chapter Sec. 1. Except as otherwise provided,
More informationTHERAPEUTIC USE EXEMPTION GUIDELINES
World Anti-Doping Programme THERAPEUTIC USE EXEMPTION GUIDELINES Version 4.0 October 2010-1 - TABLE OF CONTENTS Introduction and scope... 4 Definitions... 5 Terms defined in the Code... 5 Terms defined
More informationPHARMACEUTICAL COMMITTEE
EUROPEAN COMMISSION ENTERPRISE DIRECTORATE-GENERAL Single market : management & legislation for consumer goods Pharmaceuticals : regulatory framework and market authorisations PHARM 466 PHARMACEUTICAL
More informationREPORT 2015/168 INTERNAL AUDIT DIVISION. Audit of the operations in Thailand for the Office of the United Nations High Commissioner for Refugees
INTERNAL AUDIT DIVISION REPORT 2015/168 Audit of the operations in Thailand for the Office of the United Nations High Commissioner for Refugees Overall results relating to effective management of the operations
More informationDIVISION E INFORMATION TECHNOLOGY MANAGEMENT REFORM
DIVISION E INFORMATION TECHNOLOGY MANAGEMENT REFORM SEC. 5001. SHORT TITLE. This division may be cited as the Information Technology Management Reform Act of 1996. SEC. 5002. DEFINITIONS. In this division:
More information*Approved* GOVERNANCE AND COMPENSATION COMMITTEE November 15, 2018 TO THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
*Approved* GOVERNANCE AND COMPENSATION COMMITTEE November 15, 2018 TO THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 1. ESTABLISHMENT OF A NEW POSITION IN THE SENIOR MANAGEMENT GROUP OF ASSOCIATE VICE PRESIDENT
More informationCompetency Development: Oncology Services Clinical Redesign
Society for Radiation Oncology Administrators 32 nd Annual Meeting Competency Development: Oncology Services Clinical Redesign October 20, 2015 Session Presenter: Joseph M. Spallina, FAAMA, FACHE Director
More informationPreamble. THE GOVERNMENT OF THE UNITED STATES OF AMERICA AND THE GOVERNMENT OF THE KINGDOM OF SWEDEN (hereinafter referred to as the Parties ):
AGREEMENT BETWEEN THE GOVERNMENT OF THE UNITED STATES OF AMERICA AND THE GOVERNMENT OF THE KINGDOM OF SWEDEN ON COOPERATION IN SCIENCE AND TECHNOLOGY FOR HOMELAND SECURITY MATTERS Preamble THE GOVERNMENT
More informationGlobal Sustainability Standards Board Due Process Protocol October 2018
Global Sustainability Standards Board Due Process Protocol October 2018 The Global Sustainability Standards Board (GSSB) is authorized by its Terms of Reference to develop and issue authoritative pronouncements.
More informationNeptune s Compliance with the UK Stewardship Code
Neptune s Compliance with the UK Stewardship Code May 2014 Neptune Investment Management believes that equity ownership and the rights and responsibilities thereof are important to shareholders and reasonable
More informationLSHTM Research Ethics Committees Terms of Reference and Procedures
Contents Page 1 Background 1 2 Standards 1 3 Committees 2 4 Composition of the committees 4 5 Review of Applications 8 6 Meetings 10 7 Reporting to the Research Governance Committee 10 8 References 11
More informationCase 4:18-cv KGB Document 30 Filed 04/19/18 Page 1 of 21
Case 4:18-cv-00159-KGB Document 30 Filed 04/19/18 Page 1 of 21 Case 4:18-cv-00159-KGB Document 29-1 30 Filed 04/19/18 04/16/18 Page 23 of of 21 22 into interstate commerce, articles of drug that are adulterated
More informationSTATUTORY INSTRUMENTS. S.I. No. 443 of 2014 EUROPEAN UNION (EUROPEAN MARKETS INFRASTRUCTURE) REGULATIONS 2014
STATUTORY INSTRUMENTS. S.I. No. 443 of 2014 EUROPEAN UNION (EUROPEAN MARKETS INFRASTRUCTURE) REGULATIONS 2014 2 [443] S.I. No. 443 of 2014 EUROPEAN UNION (EUROPEAN MARKETS INFRASTRUCTURE) REGULATIONS 2014
More informationRisk and Compliance Committee Charter
Ocwen Financial Corporation Risk and Compliance Committee Charter Version 1 TABLE OF CONTENTS I. SUMMARY... 3 II. CONTENTS... 3 III. RESPONSIBILITIES AND SCOPE... 3 IV. MEMBERSHIP... 5 V. MEETINGS... 5
More informationa) Establishment of Committee A committee of the directors to be known as the "Audit Committee" (hereinafter the "Committee") is hereby established.
Charters of committees of Board of Directors of Royal Bank of Canada Excerpted from ROYAL BANK OF CANADA ADMINISTRATIVE RESOLUTIONS ADOPTED BY THE BOARD OF DIRECTORS OF ROYAL BANK OF CANADA (hereinafter
More informationINTERNATIONAL DANCE ORGANIZATION IDO ANTI-DOPING RULES
INTERNATIONAL DANCE ORGANIZATION IDO ANTI-DOPING RULES (Based upon the 2015 Code) January 2015 1 TABLE OF CONTENTS INTRODUCTION...3 PREFACE... 3 FUNDAMENTAL RATIONALE FOR THE CODE AND IDO'S ANTI-DOPING
More informationGUIDELINE FOR AUTHORISED REPRESENTATIVES
Ref. Ares(2015)2069167-18/05/2015 EUROPEAN COMMISSION DG HEALTH & CONSUMERS Directorate B -Consumer Affairs Unit B2 Health technology and Cosmetics MEDICAL DEVICES: Guidance document MEDDEV 2.5/10 January
More informationFRCC REGIONAL RELIABILITY STANDARD DEVELOPMENT PROCESS MANUAL
FRCC REGIONAL RELIABILITY STANDARD DEVELOPMENT PROCESS MANUAL FRCC-RE-STD-001 Effective Date: March 3, 2017 Version: 1 3000 Bayport Drive, Suite 600 Tampa, Florida 33607-8410 (813) 289-5644 - Phone (813)
More informationThe DG SANTE approach to evaluate food safety control systems in Member States and non EU countries
The DG SANTE approach to evaluate food safety control systems in Member States and non EU countries Stefan Hönig Directorate-General (DG SANTE) Directorate F, food audits and analysis Unit F1: Food The
More informationSAN FRANCISCO AIRPORT COMMISSION CALENDAR
SAN FRANCISCO AIRPORT COMMISSION CALENDAR March 31, 2009 Special Meeting 9:00 A.M. Room 416 - City Hall #1 Dr. Carlton B. Goodlett Place (400 Van Ness Avenue) City and County of San Francisco GAVIN NEWSOM,
More informationGROUP PURCHASING CODE OF CONDUCT
GROUP PURCHASING CODE OF CONDUCT TRANSFORMING HEALTHCARE TOGETHER GROUP PURCHASING CODE OF CONDUCT CONTENTS Group Purchasing Credo... 03 Use of Contracting Tools... 07 General Ethics Policies... 03 Compliance,
More informationWORLD ANTI-DOPING CODE. with 2018 amendments
WORLD ANTI-DOPING CODE 2015 with 2018 amendments World Anti-Doping Code The World Anti-Doping Code was first adopted in 2003, took effect in 2004, and was then amended effective 1 January 2009. The following
More informationEuropean Medicines Agency decision
EMA/781916/2015 European Medicines Agency decision P/0315/2015 of 21 December 2015 on the agreement of a paediatric investigation plan and on the granting of a waiver for ethosuximide (EMEA-001617-PIP01-14)
More informationFrequently Asked Questions for Municipalities LOCAL GOVERNMENT BODIES RECORDS
Frequently Asked Questions for Municipalities The Freedom of Information and Protection of Privacy (FOIP) Act aims to strike a balance between the public s right to know and the individual s right to privacy,
More informationBOARD OF DIRECTORS AGENDA
BOARD OF DIRECTORS AGENDA Date Issued: December 14, 2018 The Board of Directors of the Cook County Health and Hospitals (CCHHS) will meet on Friday, December 21, 2018 at the hour of 9:00 8:30 A.M., at
More informationThe Board may take action on any of the items listed below, unless the item is specifically labeled Informational Only.
TRI-CITY HEALTHCARE DISTRICT AGENDA FOR A REGULAR MEETING January 25, 2018 1:30 o clock p.m. Assembly Room 1 - Eugene L. Geil Pavilion Open Session Assembly Rooms 2&3 4002 Vista Way, Oceanside, CA 92056
More informationCase 1:17-cv Document 1 Filed 08/04/17 Page 1 of 15
Case 1:17-cv-01577 Document 1 Filed 08/04/17 Page 1 of 15 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLUMBIA UNITED THERAPEUTICS CORPORATION, 1040 Spring Street Silver Spring, MD 20910 v.
More informationMANDATE MEETINGS AND CALLING OF MEETINGS CREATION COMPOSITION NATIONAL BANK OF CANADA
NATIONAL BANK OF CANADA RISK MANAGEMENT COMMITTEE The Risk Management Committee (the Committee ) is formed by the Board of Directors (the Board ) of (the Bank ). It oversees, on the one hand, the Bank's
More informationChanges made before the study has received regulatory approvals are handled as revisions to the submission, rather than amendments.
AMENDMENTS Amendments Amendments are changes that are made to the research after review body approval has been given. Amendments cannot be implemented until the relevant approvals are in place, except
More informationQUALIFICATION OF VENDORS
Request For Quote Multi-Room Interview Recording System Lemont Police Department Date of Issuance: February 8th, 2018 Due Date for Submission: February 16th, 2018, 9:00 am PROJECT OVERVIEW The Lemont,
More informationFramework for Safeguarding in prisons and approved premises
Hampshire Safeguarding Adults Board Framework for Safeguarding in prisons and approved premises Hampshire and Isle of Wight Guidance May 2015 This framework provides guidance on adult safeguarding in prisons
More informationSUMMARY INTRODUCTION. xiii
SUMMARY INTRODUCTION The U.S. Army has a growing need to control access to its systems in times of both war and peace. In wartime, the Army s dependence on information as a tactical and strategic asset
More informationHealth Reform Law - Advisory Panels, Boards, Commissions, & Stakeholder Involvement
Reporting Requirements 1001 adding 2717 of the PHSA Health Information Transactions 1104(g) State Exchange Operations 1321(a)(2) CO-OP Advisory Board -experts in health care quality and relevant stakeholders
More informationKey Considerations for Oversight Actors
Implementing and Overseeing Electronic Voting and Counting Technologies Key Considerations for Oversight Actors Lead Authors Ben Goldsmith Holly Ruthrauff This publication is made possible by the generous
More informationCITY POLICY No. R-24
CITY POLICY No. R-24 REFERENCE: APPROVED BY: CITY COUNCIL REGULAR COUNCIL MINUTES September 8, 2008 DATE: September 8, 2008 (RES.R08-2040) HISTORY: NEW TITLE: Lobbyist Registration Policy 1. PURPOSES The
More informationREPORT 2014/052 INTERNAL AUDIT DIVISION
INTERNAL AUDIT DIVISION REPORT 2014/052 Audit of the operations of the Regional Office in South Africa for the Office of the United Nations High Commissioner for Refugees Overall results relating to the
More information1.1 The Committee operates under delegated authority from the Board.
TOR(Charter): RISK POLICY & COMPLIANCE COMMITTEE APPROVED BY: Board of Directors APPROVAL DATE: 28 February, 2017 EFFECTIVE DATE: 28 February, 2017 PREVIOUS UPDATES: 25 July, 2016, 19 February, 2016, 27
More information